Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

In 'Major Breakthrough,' Oxford Researchers Say Cheap, Available Steroid Can Save Lives From Coronavirus

Health + Wellness
In 'Major Breakthrough,' Oxford Researchers Say Cheap, Available Steroid Can Save Lives From Coronavirus
A box of dexamethasone tablets in a pharmacy on June 16, 2020 in Cardiff, United Kingdom. An Oxford researcher said that coronavirus patients should not buy the drug to take at home, but that hospitals should administer it when appropriate. Matthew Horwood / Getty Images

For the first time, scientists have found evidence that a drug can significantly help save the lives of people severely ill with COVID-19, and it's a medicine that is both cheap and widely available.


Researchers at the University of Oxford found that the steroid dexamethasone reduced the risk of death by a third for patients on ventilators and a fifth for patients on oxygen, BBC News reported. If the drug had been used in the UK from the start of the coronavirus pandemic, the researchers said, as many as 5,000 lives could have been saved.

"This is the only drug so far that has been shown to reduce mortality — and it reduces it significantly," chief investigator professor Peter Horby told BBC News. "It's a major breakthrough."

The finding is part of a broader RECOVERY clinical trial that has been testing potential coronavirus treatments since March, funding body the National Institute for Health Research (NIHR) explained. In the case of dexamethasone, 2,104 patients were randomly assigned to take the steroid once a day for 10 days and their outcomes were compared with another randomly-assigned control group of 4,321 patients who received standard care. The researchers stopped the trial early because it was working so well, The New York Times reported.

The drug has been used for more than 50 years to treat inflammatory conditions like arthritis and asthma. In the case of coronavirus, it helps prevent tissue damage caused when the immune system overreacts to the virus in a potentially deadly phenomenon known as a cytokine storm.

"What this is effectively doing is tamping down inflammatory responses in patients," Stuart Neil, a professor of virology at King's College London, told The New York Times. "It's almost certain this is affecting the body's response against the virus, rather than inhibiting the virus itself."

The steroid did not help patients who did not require oxygen and was not tested on people managing their coronavirus symptoms at home, NIHR pointed out.

Lead researcher professor Martin Landray told BBC News that patients should not buy the drug to take at home, but that hospitals should administer it when appropriate. Indeed, doctors in the UK have been authorized to do so starting Tuesday, according to The New York Times.

"The treatment is up to 10 days of dexamethasone and it costs about £5 per patient," Landray told BBC News. "So essentially it costs £35 to save a life."

But the findings have not yet been peer reviewed, leading to skepticism on the part of some U.S. doctors, Reuters reported. In the race to find a cure for the new disease, treatments have been touted then abandoned and studies have been published and then retracted, The New York Times pointed out. On Monday, the U.S. Food and Drug Administration withdrew its emergency authorization for the use of anti-malaria drugs hydroxychloroquine and chloroquine against the coronavirus. And respected journal The Lancet retracted a coronavirus study this month because of data problems.

"It will be great news if dexamethasone, a cheap steroid, really does cut deaths by 1/3 in ventilated patients with COVID19, but after all the retractions and walk backs, it is unacceptable to tout study results by press release without releasing the paper," writer and surgeon Atul Gawande tweeted.

South Korea's top health official urged caution in prescribing dexamethasone because of potential side effects, and several U.S. doctors said they would wait for a peer-reviewed article to make their final judgment, according to Reuters.

"We have been burned before, not just during the coronavirus pandemic but even pre-COVID, with exciting results that when we have access to the data are not as convincing," Dr. Kathryn Hibbert, who directs the medical intensive care unit at Harvard's Massachusetts General Hospital, told Reuters.

An Asian giant hornet taken from the first U.S. nest to be discovered. ELAINE THOMPSON / POOL / AFP via Getty Images

The first U.S. "murder hornet" nest has been discovered and eliminated.

Read More Show Less

EcoWatch Daily Newsletter

An aerial view shows drought conditions in the Amazon rainforest on Feb. 20, 2015 in Brazil. Lena Trindade / Brazil Photos / LightRocket / Getty Images

By Jennifer Ann Thomas

For the first time, researchers have developed a model capable of anticipating drought periods in the Amazon up to 18 months in advance. The study was conducted by scientists from the Potsdam Institute for Climate Impact Research (PIK), in Germany, as part of the Tipping Points in the Earth System (TiPES) project, led by physicist Catrin Ciemer and published in the journal Environmental Research Letters.

Read More Show Less

Trending

Are you noticing your shirts becoming too tight fitting to wear? Have you been regularly visiting a gym, yet it seems like your effort is not enough? It's okay to get disappointed, but not to lose hope.

Read More Show Less
People take a group selfie on top of Parliament Hill in north London, Britain, on Oct. 25, 2020. There have been "dramatic improvements in London's air quality" since 2016, Mayor Sadiq Khan announced. Xinhua / Han Yan via Getty Images

By Sean Fleming

Londoners worrying about air quality can now breathe a little easier, thanks to news from the city's mayor.

Read More Show Less
Japan's Prime Minister Suga Yoshihide poses for a portrait on September 14, 2020 in Tokyo, Japan, after being elected Liberal Democratic Party President. Nicolas Datiche / Pool / Getty Images

Japanese Prime Minister Yoshihide Suga announced that Japan will become country carbon neutral by 2050, Bloomberg reported.

Read More Show Less

Support Ecowatch